Cysteinyl-leukotriene receptor antagonists: present situation and future opportunities.
about
The Potential Role of 8-Oxoguanine DNA Glycosylase-Driven DNA Base Excision Repair in Exercise-Induced AsthmaLeukotrienes as modifiers of preclinical atherosclerosis?Update on leukotriene, lipoxin and oxoeicosanoid receptors: IUPHAR Review 7Oxpholipin 11D: an anti-inflammatory peptide that binds cholesterol and oxidized phospholipidsThe leukotriene receptor antagonist montelukast and its possible role in the cardiovascular field.Pranlukast prevents cysteinyl leukotriene-induced emesis in the least shrew (Cryptotis parva).The employment of leukotriene antagonists in cutaneous diseases belonging to allergological fieldUrticaria and angioedema.Advances in mast cell biology: new understanding of heterogeneity and function.Eicosanoids and their drugs in cardiovascular diseases: focus on atherosclerosis and stroke.Synthesis of tenascin and laminin beta2 chain in human bronchial epithelial cells is enhanced by cysteinyl leukotrienes via CysLT1 receptor.A role for inflammatory mediators in heterologous desensitization of CysLT1 receptor in human monocytes.Expression of cysLT1 and cysLT2 receptor in chronic hyperplastic eosinophilic sinusitis.Treatment with the leukotriene inhibitor montelukast for 10 days attenuates portal hypertension in rat liver cirrhosis.Cysteinyl leukotrienes regulate endothelial cell inflammatory and proliferative signals through CysLT₂ and CysLT₁ receptors.Cysteinyl-leukotriene receptor antagonist montelukast decreases blood-brain barrier permeability but does not prevent oedema formation in traumatic brain injury.
P2860
Q26741540-288A88FC-9882-494E-B5A8-AF56B72CA659Q27025129-383A5F05-FE45-4EE0-9BBB-101779185F03Q28308192-4319BF59-0CA5-467D-A131-CD9F4977556FQ28752575-49E7F3EF-043D-4B8C-99E8-51E96BA0E3FEQ30234961-005C2859-D49F-49AC-8ED8-6D1C7DB36760Q33638271-C83C796D-9807-4925-AB97-930A03B752D3Q34141112-80A00633-5228-4272-B7A2-8792A452330AQ34215915-F42EBC9A-964E-4401-8210-575F70C00341Q37665290-036EBA4B-94B9-469B-AE5F-F87C751CA154Q37995534-0BBDCDFD-EDEE-4DB7-A32A-2E387F3F353FQ38843448-A03729C4-DE82-4644-BEB1-CB32E435D183Q39766422-760AFC7C-E94F-452C-B31E-C09E305C1E18Q41949327-DAC0C413-A8E5-41D4-8B13-CA04BA5CB7B2Q42472251-FE82B90D-7908-4111-9508-F190D0289752Q42876825-371B581C-F15A-45E6-99C1-A5790E5428A1Q45988519-22928103-5199-4732-ACDC-5F12385B92EF
P2860
Cysteinyl-leukotriene receptor antagonists: present situation and future opportunities.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Cysteinyl-leukotriene receptor antagonists: present situation and future opportunities.
@ast
Cysteinyl-leukotriene receptor antagonists: present situation and future opportunities.
@en
type
label
Cysteinyl-leukotriene receptor antagonists: present situation and future opportunities.
@ast
Cysteinyl-leukotriene receptor antagonists: present situation and future opportunities.
@en
prefLabel
Cysteinyl-leukotriene receptor antagonists: present situation and future opportunities.
@ast
Cysteinyl-leukotriene receptor antagonists: present situation and future opportunities.
@en
P2093
P1476
Cysteinyl-leukotriene receptor antagonists: present situation and future opportunities.
@en
P2093
P304
P356
10.2174/092986706778742963
P577
2006-01-01T00:00:00Z